Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use

International Journal of Pharmaceutics

Volumn 137, Issue 2, 1996, Pages 233-241

  Edsman, Katarina ^a   Carlfors, Johan ^a,b   Harju, Kaisa ^b,c  

^a PFIZER INC   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

Area under the curve (AUC); Bioavailability; Carbomer; Carbopol 1342NF; Carbopol 974P; Gel; Noveon AA1; Ocular residence time; Pilocarpine; Rheology

Indexed keywords

CARBOMER; PILOCARPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; EYE; GEL; HUMAN; HUMAN EXPERIMENT; MIOSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; TOPICAL DRUG ADMINISTRATION; VISCOELASTICITY;

EID: 0030604684     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04525-5     Document Type: Article

References (14)

1. Asseff, C.F., Weisman, R.L., Podos, S.M. and Becker, B., Ocular penetration of pilocarpine in primates. Am. J. Ophthalmol., 75 (1973) 212-215.
2. Cox, W.P. and Merz, E.H. Correlation of dynamic and steadyflow viscosities. J. Polymer Sci., 28 (1958) 619-622.
3. Craig, D.M.Q., Tamburic, S., Buckton, G. and Newton, J.M., An investigation into the structure and properties of Carbopol 934 gels using dielectric spectroscopy and oscillatory rheometry. J. Controlled Release, 30 (1994) 213-223.
4. Duchene, D., Touchard, F. and Peppas, N.A., Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev. Ind. Pharmacy, 14 (1988) 283-318.
5. Grass, G.M. and Robinson, J.R., Relationship of chemical structure to corneal penetration and influence of low viscosity solutions on ocular bioavailability. J. Pharm. Sci., 73 (1984) 1021-1027.
6. Hardberger, R., Hanna, C. and Boyd, C.M., Effects of drug vehicles on ocular contact time. Arch. Ophthalmol., 93 (1975) 42-45.
7. Lee, V.H.L., Minimising the systemic absorption of topically applied ophthalmic drugs in rabbits. STP Pharma Sci., 2 (1992) 5-12.
8. March, W.F., Stewart, R.M., Mandell, A.I. and Bruce, L.A., Duration of effect of pilocarpine gel. Arch. Ophthalmol., 100 (1982) 1270-1271.
9. Massey, J.Y., Hanna, C., Goodart, R. and Wallace, T., Effect of drug vehicle on human ocular retention of topically applied tetracycline. Am. J. Ophthalmol., 81 (1976) 151-156.
10. Robinson, J.R., Ocular drug delivery. Mechanism(s) of corneal drug transport and mucoadhesive delivery systems, STP Pharma, 5 (1989) 839-846.
11. Shell, J.W., Ophthalmic drug delivery systems. Drug Dev. Res., 6 (1985) 245-261.
12. Shell, J.W., Ocular drug delivery systems - a review. J. Toxicol. Cut. Ocular Toxicol., 1 (1982) 49-63.
13. Sieg, J.W. and Robinson, J.R., Vehicle effects on ocular drug bioavailability. I. Evaluation of fluorometholone. J. Pharm. Sci., 64 (1975) 931-936.
14. Smart, J.D., In vitro assessment of some mucosa adhesive dosage forms. Int. J. Pharm., 73 (1991) 69-74.